1. Home
  2. BTOC vs MBRX Comparison

BTOC vs MBRX Comparison

Compare BTOC & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.32

Market Cap

14.3M

Sector

N/A

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.66

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
MBRX
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
13.1M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
BTOC
MBRX
Price
$0.32
$2.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$61.00
AVG Volume (30 Days)
301.8K
229.9K
Earning Date
05-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$0.25
52 Week High
$1.78
$7.98

Technical Indicators

Market Signals
Indicator
BTOC
MBRX
Relative Strength Index (RSI) 50.60 57.18
Support Level $0.27 $2.24
Resistance Level $0.33 $2.95
Average True Range (ATR) 0.03 0.22
MACD -0.00 0.01
Stochastic Oscillator 20.53 50.82

Price Performance

Historical Comparison
BTOC
MBRX

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: